login / register

Global Blood Therapeutics said to draw takeover interest, reveals Bloomberg - Part 2

It would appear Johnson & Johnson was also circling US-listed Global Blood Therapeutics, which two weeks ago agreed a deal to sell itself to pharmaceutical giant Pfizer for $5.4 billion.

Well, that's according to arch rivals at Bloomberg. Below is a link to the Bloomie story that came out overnight:..

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Wednesday, 24 August 2022, 9:07 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation